Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glenmark Pharmaceuticals
Biotech
Glenmark bags subcutaneous checkpoint inhibitor rights
Glenmark agreed to pay "low double digit millions" for the chance to launch envafolimab in markets including India.
Nick Paul Taylor
Jan 25, 2024 9:30am
Intima snags Gilead's former Yescarta leader for cell Tx chops
Nov 10, 2021 10:10am
Novartis Oncology veterans reunite at Glenmark spinoff Ichnos
Feb 5, 2020 10:14am
Alessandro Riva to leave Gilead to lead Glenmark spinoff
Mar 6, 2019 9:43am
India’s Glenmark spins out NMEs into U.S. company
Feb 15, 2019 8:55am
Intellia clinical head to be Casebia’s 1st CMO—Chutes & Ladders
Nov 2, 2018 9:00am